Can Propranalol Prevent Hepatocellular Carcinoma?
Cancer Prevention Research, 08/08/2012
London WT et al. – The finding suggest that the β–blocker propranolol was associated with a highly statistically significant reduction in the incidence of hepatocellular carcinoma in patients with advanced cirrhosis and related esophageal varices.



